Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ming Zeng

Showing results (1201-1210 of 1,217) with videos related to

Pageof 122
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|May 1, 2013
Central role of liver in anticancer and radioprotective activities of Toll-like receptor 5 agonistLyudmila G Burdelya, Craig M Brackett, Bojidar Kojouharov, et al.
The Journal of Clinical Investigation|January 15, 2026
EGFR activation disrupts immunotherapy response via SHP2-mediated suppression of tumor-intrinsic response to IFN-γWei-Tao Zhuang, Lan-Lan Pang, Li-Yang Hu, et al.
BMC Cancer|May 9, 2023
Radiographic and α-fetoprotein response predict pathologic complete response to immunotherapy plus a TKI in hepatocellular carcinoma: a multicenter studyCheng Huang, Xiao-Dong Zhu, Ying-Hao Shen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 20, 2014
Live simian immunodeficiency virus vaccine correlate of protection: local antibody production and concentration on the path of virus entryQingsheng Li, Ming Zeng, Lijie Duan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 22, 2022
A Phase III Multicenter Randomized Clinical Trial of 60 Gy versus 50 Gy Radiation Dose in Concurrent Chemoradiotherapy for Inoperable Esophageal Squamous Cell CarcinomaYujin Xu, Baiqiang Dong, Weiguo Zhu, et al.
Liver Cancer|August 21, 2023
Tumor Radiomic Features on Pretreatment MRI to Predict Response to Lenvatinib plus an Anti-PD-1 Antibody in Advanced Hepatocellular Carcinoma: A Multicenter StudyBin Xu, San-Yuan Dong, Xue-Li Bai, et al.
Journal of the National Cancer Institute|January 30, 2022
Randomized Trial of First-Line Tyrosine Kinase Inhibitor With or Without Radiotherapy for Synchronous Oligometastatic EGFR-Mutated Non-Small Cell Lung CancerXiao-Shan Wang, Yi-Feng Bai, Vivek Verma, et al.
Nature Immunology|August 20, 2021
Selenium-GPX4 axis protects follicular helper T cells from ferroptosisYin Yao, Zhian Chen, Hao Zhang, et al.
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi = Journal of Clinical Otorhinolaryngology Head and Neck Surgery|June 10, 2024
[Expert consensus on the diagnosis and treatment of respiratory diseases exacerbated by nonsteroidal anti-inflammatory drugs (2024, Chengdu)]Juan Meng, Jing Ye, LiJiang Zhang, et al.
Iscience|July 1, 2026
Proteomics and human microchips identify Thrombospondin-1 as a potential biomarker for calciphylaxis stem cell therapyJiaying Hu, Shijiu Lu, Lianju Qin, et al.
Pageof 122

Showing results (1201-1210 of 1,217) with videos related to

Sort By:
Pageof 122
Proceedings of the National Academy of Sciences of the United States of America|May 1, 2013
Central role of liver in anticancer and radioprotective activities of Toll-like receptor 5 agonistLyudmila G Burdelya, Craig M Brackett, Bojidar Kojouharov, et al.
The Journal of Clinical Investigation|January 15, 2026
EGFR activation disrupts immunotherapy response via SHP2-mediated suppression of tumor-intrinsic response to IFN-γWei-Tao Zhuang, Lan-Lan Pang, Li-Yang Hu, et al.
BMC Cancer|May 9, 2023
Radiographic and α-fetoprotein response predict pathologic complete response to immunotherapy plus a TKI in hepatocellular carcinoma: a multicenter studyCheng Huang, Xiao-Dong Zhu, Ying-Hao Shen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 20, 2014
Live simian immunodeficiency virus vaccine correlate of protection: local antibody production and concentration on the path of virus entryQingsheng Li, Ming Zeng, Lijie Duan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 22, 2022
A Phase III Multicenter Randomized Clinical Trial of 60 Gy versus 50 Gy Radiation Dose in Concurrent Chemoradiotherapy for Inoperable Esophageal Squamous Cell CarcinomaYujin Xu, Baiqiang Dong, Weiguo Zhu, et al.
Liver Cancer|August 21, 2023
Tumor Radiomic Features on Pretreatment MRI to Predict Response to Lenvatinib plus an Anti-PD-1 Antibody in Advanced Hepatocellular Carcinoma: A Multicenter StudyBin Xu, San-Yuan Dong, Xue-Li Bai, et al.
Journal of the National Cancer Institute|January 30, 2022
Randomized Trial of First-Line Tyrosine Kinase Inhibitor With or Without Radiotherapy for Synchronous Oligometastatic EGFR-Mutated Non-Small Cell Lung CancerXiao-Shan Wang, Yi-Feng Bai, Vivek Verma, et al.
Nature Immunology|August 20, 2021
Selenium-GPX4 axis protects follicular helper T cells from ferroptosisYin Yao, Zhian Chen, Hao Zhang, et al.
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi = Journal of Clinical Otorhinolaryngology Head and Neck Surgery|June 10, 2024
[Expert consensus on the diagnosis and treatment of respiratory diseases exacerbated by nonsteroidal anti-inflammatory drugs (2024, Chengdu)]Juan Meng, Jing Ye, LiJiang Zhang, et al.
Iscience|July 1, 2026
Proteomics and human microchips identify Thrombospondin-1 as a potential biomarker for calciphylaxis stem cell therapyJiaying Hu, Shijiu Lu, Lianju Qin, et al.
Pageof 122